FRASSOLDATI, ALICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 380
EU - Europa 157
AS - Asia 94
AF - Africa 2
OC - Oceania 1
Totale 634
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 374
IE - Irlanda 46
IT - Italia 32
HK - Hong Kong 28
CN - Cina 26
GB - Regno Unito 26
SG - Singapore 23
SE - Svezia 22
ID - Indonesia 8
CA - Canada 6
FI - Finlandia 6
BE - Belgio 5
BG - Bulgaria 4
DE - Germania 4
VN - Vietnam 4
TR - Turchia 3
ES - Italia 2
FR - Francia 2
NL - Olanda 2
AU - Australia 1
BJ - Benin 1
CZ - Repubblica Ceca 1
GR - Grecia 1
IN - India 1
MY - Malesia 1
NG - Nigeria 1
PL - Polonia 1
RO - Romania 1
RU - Federazione Russa 1
UA - Ucraina 1
Totale 634
Salva come PNG Salva come JPEG
Città #
Santa Clara 61
Chandler 54
Dublin 46
Fairfield 42
Ashburn 28
Hong Kong 28
Woodbridge 21
Houston 20
Nyköping 20
Singapore 18
Cambridge 17
Seattle 15
Ann Arbor 14
San Diego 14
Southend 14
Wilmington 11
Jakarta 8
Modena 8
Helsinki 6
Princeton 6
Shanghai 5
Des Moines 4
Dong Ket 4
Sofia 4
Carpi 3
Kilburn 3
London 3
Ottawa 3
Rome 3
Toronto 3
Wuhan 3
Boom 2
Bremen 2
Brussels 2
Eugene 2
Gazi 2
Guangzhou 2
Los Angeles 2
Nanjing 2
Norwalk 2
Pisa 2
Redwood City 2
Shenzhen 2
Albiate 1
Athens 1
Beijing 1
Boardman 1
Brno 1
Changsha 1
Chicago 1
Chiswick 1
Cotonou 1
Cupertino 1
Denver 1
Fremont 1
Groningen 1
Hangzhou 1
Hounslow 1
Laurel 1
Lucca 1
North Bergen 1
Para 1
Parma 1
Torino 1
Turin 1
Unirea 1
Vigevano 1
Wandsworth 1
Totale 538
Salva come PNG Salva come JPEG
Nome #
Practice patterns regarding drains management in breast surgery: Results of a survey of Senonetwork Italia breast centers 180
Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials (Breast Cancer Research and Treatment, (2017), 163, 2, (295-302), 10.1007/s10549-017-4191-y) 154
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio 121
Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer: Survival analyses of the CHER-Lob trial 107
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial 81
Totale 643
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.487
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.487
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 0 0 0 0 0 0 0 0 0 0 11 8
2020/2021142 9 2 12 6 7 5 41 23 10 10 8 9
2021/2022127 3 20 1 4 2 12 9 1 19 11 33 12
2022/2023172 11 25 7 13 11 19 2 14 62 0 2 6
2023/202476 2 5 6 4 13 2 14 12 0 3 5 10
2024/2025107 9 0 3 17 45 33 0 0 0 0 0 0
Totale 643